Pulmonary Embolism Removal with the AngioJet 6F Ultra SystEm (PERFUSE)

• Research type

  Research Study

• Full title

  Pulmonary Embolism Removal with the AngioJet 6F Ultra SystEm (PERFUSE)

• IRAS ID

  111145

• Contact name

  Usman Shaikh

• Contact email

  usman.shaikh@rlbuht.nhs.uk

• Sponsor organisation

  Bayer Healthcare (previously MEDRAD)

• Clinicaltrials.gov Identifier

  NCT01638468

• Duration of Study in the UK

  2 years, 4 months, 25 days

• Research summary

  The objective of this post market follow-up study is to characterize the efficacy and safety of the AngioJet Ultra PE Thrombectomy Catheter System for treatment of pulmonary embolism in which the goal of thrombectomy treatment is to demonstrate improvement in the Right Ventricular to Left Ventricular ratio as measured by echocardiography. Up to 50 patients with pulmonary embolism at up to 15 European sites will participate. Patients will participate in a 3 month follow up.

• REC name

  North West - Greater Manchester South Research Ethics Committee

• REC reference

  15/NW/0080

• Date of REC Opinion

  7 Apr 2015

• REC opinion

  Further Information Favourable Opinion